A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain

Ended Cooperative Agreement Awarded Last action

Award ID
UH3AR077360
Recipient
Awarding agency
Obligated
$41,956,441

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date
Originally
Funding
  • $35,860,092.00 Federal
  • $6,096,349.34 Non-federal
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Place of performance
Maryland, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment -$190,460 $0
Amendment -$190,460 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $155,563 $0
Amendment $155,563 $0
Amendment $155,563 $0
Amendment $1 $0
Amendment $1,164,062 $0
Amendment $1,164,062 $0
Amendment $1,164,062 $0
Amendment $1,164,062 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1 $0
Amendment $155,563 $0
Amendment $155,563 $0
Amendment $1 $0
Amendment $1 $0
Amendment $2,951,097 $0
Amendment $2,951,097 $0
Amendment $2,951,097 $0
Amendment $0 $0
Amendment $0 $0
Amendment $523,792 $0
Amendment $523,792 $523,792
Amendment Increasing participant diversity in a 'sequenced-strategy to improve outcomes in people with knee osteoarthritis pain (skoap) $523,792 $0
Amendment $190,460 $0
Amendment Increasing participant diversity in a 'sequenced-strategy to improve outcomes in people with knee osteoarthritis pain (skoap) $190,460 $0
Amendment $190,460 $190,460
Amendment $155,563 $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
Northwestern University Recognizing the need for greater representation of minoritized patients in clinical trials, Northwestern University will utilize diversity supplement funds to… $927,395
Wake Forest University A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain $1,690,602
University Of Utah $677,818
The Regents Of The University Of Colorado $128,261
University Of Washington $224,771
The University Of Iowa A sequenced-strategy for improving outcomes in patients with knee osteoarthritis $300,547
Emory University $201,743
The Cleveland VA Medical Research & Education Foundation $176,450
Rector & Visitors Of The University Of Virginia A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain $176,351
Regents Of The University Of Minnesota $96,313
Duke University A sequenced-strategy for improving outcomes in patients with knee osteoarthritis $205,436
Case Western Reserve University Arthritis, Musculoskeletal and Skin Diseases Research $127,541
Vanderbilt University Medical Center Recognizing the need for greater representation of minoritized patients in clinical trials, Northwestern University will utilize diversity supplement funds to… $358,988
University Of California, Davis A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain $99,881
University Of Florida $138,209
Veterans Medical Research Foundation Of San Diego $99,366
The Geneva Foundation $92,109
Oregon Health & Science University $124,488
Foundation For Atlanta Veterans Education And Research, Inc. The subrecipient will be enrolling clinic patients ages 18 to 90 with a confirmed diagnosis of knee osteoarthritis per the American College of Rheumatology… $46,469
University Of California, San Diego A sequenced-strategy for improving outcomes in patients with knee osteoarthritis $463,340
University Of North Carolina At Chapel Hill A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain $96,903
Brigham & Womens Hospital Inc. A􀀃sequenced�strategy􀀃for􀀃improving􀀃outcomes􀀃in􀀃patients􀀃with􀀃knee􀀃… $345,048
University Of Rochester A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain $55,096
Weill Medical College Of Cornell University Recognizing the need for greater representation of minoritized patients in clinical trials, Northwestern University will utilize diversity supplement funds to… $97,675
Wake Forest University A sequenced-strategy for improving outcomes in patients with knee osteoarthritis $242,267
University Of Maryland, Baltimore $42,349
Mayo Clinic A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain $71,927
The Trustees Of Columbia University In The City Of New York $31,736
Show all 28

Quick answers

Who received award UH3AR077360?

UH3AR077360 was awarded to The Johns Hopkins University by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 25, 2019.

How much is award UH3AR077360 worth?

$41,956,441 has been obligated on UH3AR077360: $35,860,092 in federal funding and $6,096,349 in non-federal funding.

Which agency awarded UH3AR077360?

National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) awarded UH3AR077360, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award